EDIT vs L
Editas Medicine Inc (EDIT) versus Loews Corp (L) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported L revenue for 2024-12-31 was $17.51B. Net income was $1.49B. Revenue was up 10.1% from 2023-12-31 to 2024-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
EDIT currently screens at market cap $375.2M. L currently screens at market cap $22.36B and trailing P/E 13.8.
Not investment advice. Open the EDIT and L stock pages for the full models.
Not investment advice.